Search - tctmd.com

Displaying 161 - 180 of 211

Sort: Relevancy | Date

Presentation TCT 2014

DCB ONLY and Vascular Restoration: Insights from Intracoronary OCT Human Studies

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Tudor C Poerner

September 13, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

Presentation CTO 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presenter: Antonio Colombo

March 01, 2014

Presentation CTO 2014

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Presenter: Philippe Généreux

March 01, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

Presentation

Role of Drug Coated Balloons in Acute Coronary Syndrome

Presenter: Bruno Scheller

December 02, 2013

Presentation

Drug-Coated Balloons for Treatment of Coronary Artery Disease: Updated Recommendations from a Consensus Group

Presenter: Bruno Scheller

December 01, 2013

Presentation TCT 2013

Trial Design and Regulatory Pathways for Drug-Coated Balloons in BTK Intervention: Anatomy, Patients and Endpoints

Presenter: William Gray

October 31, 2013

Presentation TCT 2013

CON: Drug-Coated Balloons are Effective at the Arterial Level, But Not Necessarily for the Patient!

Presenter: Michael Conte

October 31, 2013

Presentation TCT 2013

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Presenter: Thomas Zeller

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Presenter: Ron Waksman

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Presenter: Christoph Naber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Presenter: Franz Kleber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data

Presenter: Franz Kleber

October 31, 2013

Presentation TCT 2013

Coronary Drug-Coated Balloons in De Novo Lesions: What are the Technical and Safety Considerations That Haven't Been Addressed?

Presenter: Bernardo Cortese

October 31, 2013

Advertisement

DCB ONLY and Vascular Restoration: Insights from Intracoronary OCT Human Studies

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Role of Drug Coated Balloons in Acute Coronary Syndrome

Drug-Coated Balloons for Treatment of Coronary Artery Disease: Updated Recommendations from a Consensus Group

Trial Design and Regulatory Pathways for Drug-Coated Balloons in BTK Intervention: Anatomy, Patients and Endpoints

CON: Drug-Coated Balloons are Effective at the Arterial Level, But Not Necessarily for the Patient!

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data

Coronary Drug-Coated Balloons in De Novo Lesions: What are the Technical and Safety Considerations That Haven't Been Addressed?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content